NCT07374861Recruiting
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy
Source: ClinicalTrials.gov · Last updated 29 Jan 2026
Brief summary (registry, in English)
Evaluation of adherence, persistence, and efficacy of treatment with Bempedoic acid in a real-life Italian population.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 21 Jan 2026
- Start date
- 4 Nov 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Federico II University
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT07374861
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 4 Nov 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \< 18 years o \> 80 years
Other
- Patients who refuse to participate and to sign informed consent
Who the study is looking for
- Patients under Bempedoic acid treatment
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Federico II University of Naples, Department of Advanced Biomedical Sciences Coordinator of this site? Confirm its status | Naples | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.